-
1
-
-
0025968957
-
The Changing Pattern of Post-transplant Malignancies
-
of interest, An interesting overview of the incidence of cancer in organ transplant recipients from the Cincinatti Transplant Tumor Registry.
-
(1991)
Transplant Proc
, vol.23
, pp. 1101-1103
-
-
Penn1
-
2
-
-
0025897393
-
Immunosuppression in Renal Transplantation. 1. Cyclosporine and Azathioprine
-
of interest, An excellent current review of the clinical use of these two drugs in the prevention and treatment of graft rejection.
-
(1991)
Clin Transplantation
, vol.5
, pp. 65-85
-
-
Gruber1
Chan2
Canafax3
Matas4
-
3
-
-
0026030793
-
Beneficial Effects of Prophylactic OKT3 in Cadaver Kidney Transplan tation: Comparison with Cyclosporine A in a Single-Center Prospective Randomised Study
-
of interest, A prospective randomized study of sequential therapy with OKT3 versus triple therapy, showing graft survival of over 90% at 1 year in the former compared to around 80% in the latter.
-
(1991)
Transplantation Proc
, vol.23
, pp. 1046-1047
-
-
Goldman1
Abramowicz2
De Paula3
Mareaux4
Vanderwinden5
Kinnaert6
Vereerstraeten7
-
4
-
-
85025340034
-
Cyclosporine-induced renal dysfunction in experimental animals and humans
-
of interest, A thorough review of this major complication of cyclosporine therapy.
-
(1991)
Transplantation Reviews
, vol.5
, pp. 63-70
-
-
Perico1
Remizzu2
-
5
-
-
0026071093
-
A Retrospective Analysis of Late Renal Graft Function: Correlation with Mean Cyclosporine Levels and Lack of Evidence for Chronic Cyclosporine Toxicity
-
of interest, An intriguing retrospective study of patients with kidney transplants suggesting that poor long-term renal function is associated with low cyclosporine blood levels, and thus may be a result of chronic rejection rather than cyclosporine nephrotoxicity. The results of prospective studies that are in progress are awaited with interest.
-
(1991)
Transplantation Proc
, vol.23
, pp. 1018-1019
-
-
Salomon1
Brunson2
Vansickier3
Pfaff4
Howard5
Peterson6
Curry7
Thompson8
Squires9
-
6
-
-
0024814684
-
Immunosuppressive drugs
-
of interest, An earlier review in a series describing FK506, rapamycin, mizoribine, RS-6144, and 15-deoxyspergualin.
-
(1990)
Current Opinion in Immunology
, vol.2
, pp. 854-858
-
-
St Collier1
-
7
-
-
0025962242
-
FK506: an Inlmunosuppressant for the 1990s
-
of interest, A short but thorough review of the mechanisms of action, toxicity and clinical use of FK506 in man.
-
(1991)
Lancet
, vol.337
, pp. 25-27
-
-
McCleod1
Thomson2
-
8
-
-
0026093037
-
FK506: Short and Long Term Treatment after Cardiac Transplantation in Non-Human Primates
-
of interest, Heterotopic cardiac transplants were performed in chacma baboons given FK506 for 14 days or continuously. Both short term and continuous therapy produced long-term survival. After stopping FK506, acute rejection occurred after 20 days, but reintroduction of the drug led to reversal of the rejection episode.
-
(1991)
Transplantation Proc
, vol.23
, pp. 509-510
-
-
Hillebrandt1
Meiser2
Human3
Reichenspurner4
Rose5
Odell6
Reichakt7
-
9
-
-
0025635897
-
The Cytosofic-Binding Protein for the Immunosuppressant FK506 is Both a Ubiquitous and Highly Conserved Peptidyl-Prolyl Cis-transIsomerase
-
of outstanding interest, FKBP is not a lymphoid-specific protein but is widely distributed and phylogenetically conserved, suggesting an important biological role for this protein in all eukaryotic cells.
-
(1990)
J Biol Chem
, vol.265
, pp. 2101-2105
-
-
Siekierka1
Wiederecht2
Grenlich3
Boulton4
Hung5
Cryan6
Hodges7
Sigal8
-
10
-
-
0026068924
-
Selected Topics on FK506, with Special Reference to Rescue of Extrahepatic Whole Organ Grafts, Transplantation of ‘Forbidden Organs’, Side Effects, Mechanisms and Practical Pharmacokinetics
-
of interest, The highlights of the initial Pittsburgh experience with FK506.
-
(1991)
Transplantation Proc
, vol.23
, pp. 914-919
-
-
Starzl1
Abu Elmagar2
Tzakis3
Fung4
Porter5
Todo6
-
11
-
-
0025971185
-
Conversion of Liver Allograft Recipients from Cyclosporine to FK506-Based Immunosuppression: Benefits and Pitfalls
-
of outstanding interest, Documents impressive results after conversion of patients with failing liver transplants to FK506, 70% of these being in the presence of rejection refractory to treatment with OKT3.
-
(1991)
Transplantation Proc
, vol.23
, pp. 14-21
-
-
Fung1
Todo2
Tzakis3
Demetris4
Jain5
Abu-Elmagd6
Alessiani7
Starzl8
-
12
-
-
0026085612
-
Kidney Transplantations under FK506 Immunosuppression
-
of interest, In a fairly typical group of 65 patients receiving 66 kidney transplants and treated with FK506 and steroids, the early results are unremarkable: 27% of the patients needed OKT3 treatment. However, of 52 patients with functioning grafts, steroids were discontinued in 60%. Randomized prospective trials are required.
-
(1991)
Transplantation Proc
, vol.23
, pp. 920-923
-
-
Shapiro1
Jordan2
Fung3
McCauley4
Johnston5
Iwaki6
Tzakis7
Hakaia8
Todo9
Starzl10
-
14
-
-
0026063950
-
Use Of Rapamycin for the Suppression of Alloimmune Reactions In Vivo: Schedule Dependence, Tolerance Induction, Synergy with Cyclosporine and FK506, and Effect on Host-VersusGraft and Graft-Versus-Host Reactions
-
of interest, A useful summary of the in vivo immunosuppressive properties of rapamycin.
-
(1991)
Transplantation Proc
, vol.23
, pp. 521-524
-
-
Morris1
Meiser2
Wu3
Shorthouse4
Wang5
-
15
-
-
0025647885
-
Two Distinct Signal Transmission Pathways in T Lymphocytes are Inhibited by Complexes Formed Between an Immunophilin and Either FK506 or Rapamycin
-
of outstanding interest, Although both rapamycin and FK506 are of a similar molecular structure and both bind to the same, or a closely adjoining, receptor on the FKBP, their different immunosuppressive properties suggest that the immunophilin drug complex affects different signal transduction pathways.
-
(1990)
Proc Natl Acad Sci USA
, vol.87
, pp. 9231-9235
-
-
Bierer1
Mattila2
Standaert3
Herzenberg4
Burakoff5
Grabtree6
Schreiber7
-
16
-
-
0026031552
-
Comparison of the Immunosuppressive Effects of Mycophenolic and the Morpholinoethyl Ester of Mycophenolic Acid (RS-61443) in Recipients of Heart AIlografts
-
of outstanding interest, An interesting comparison of the effect of RS and mycophenolic acid, to which the former is hydrolyzed, in a rat cardiac allograft model.
-
(1991)
Transplantation Proc
, vol.23
, pp. 493-496
-
-
Morris1
Wang2
-
18
-
-
0025981270
-
RS-61443 — a New Potent Immunosuppressive Agent
-
of outstanding interest, In a kidney allograft model in the dog, RS used alone prolonged graft survival to a median of 36 days but when combined with low dose cyclosporine (5mg/kg) and steroids, median graft survival was 122 days.
-
(1991)
Transplantation
, vol.51
, pp. 27-31
-
-
Platz1
Sollinger2
Hullett3
Eckhoff4
Eugin5
Allison6
-
19
-
-
0025904848
-
Deoxyspergualin in Lethal Murine Graft-Versus-Host Disease
-
of interest, Deoxyspergualin was able to suppress GVH disease in this model of lethal GVH disease (bone marrow and spleen cells from C457BI/6 mice to lethally irradiated CBA mice) with long-term survivors being stable chimaeras. The concomitant administration of methotrexate enhanced the suppression of GVH disease more than the use of either agent alone.
-
(1991)
Transplantation
, vol.51
, pp. 712-715
-
-
Nemoto1
Hayashi2
Ito3
Sugawara4
Mae5
Fugii6
Abe7
Fujii8
Tachenchi9
-
20
-
-
0025979981
-
Inhibition of Antibody Production by the Immunosuppressive Agent, 15-Deoxyspergualin
-
of interest, 15-deoxyspergualin completely ablates the primary response to sheep red blood cells in mice as well as the response to the soluble protein keyhole limpet haemocyuiin (KLH). However, memory of KLH in a primed recipient is only inhibited to a modest extent by the drug.
-
(1991)
Transplantation Proc
, vol.23
, pp. 328-331
-
-
Tepper1
Petty2
Bursuker3
Pasternak4
Cleaveland5
Spitasny6
Schacter7
-
21
-
-
0026030803
-
Prophylactic Use of a New Immunosuppressive Agent, Deoxyspergualin, in Patients with Kidney Transplantation from ABO-Incompatible or Preformed Antibody Positive Donors
-
of interest, Deoxyspergualin has been used as one of the immunosuppressive agents in a very heavy immunosuppressive protocol in these high risk recipients of living related renal transplants. Recipients were plasmapheresed before transplantation and in addition to deoxyspergualin received cyclosporine, azathioprine, steroids and ALG after transplantation at which time splenectomy was also performed. Nevertheless the results are impressive in that only one of eighteen grafts was lost from rejection, but it is not possible to evaluate the role of deoxyspergualin in these results.
-
(1991)
Transplantation Proc
, vol.23
, pp. 1078-1082
-
-
Takahashi1
Tanabe2
Ooba3
Yagisawa4
Nakazawa5
Teraoka6
Hayasaka7
Kawaguchi8
Ito9
Toma10
|